Sangers sequencing service involves copying single-stranded DNA with chemically altered bases called dideoxynucleotides which when incorporated at the 3' end of the growing chain, terminate the chain selectively at A, C, G, or T. The terminated chains are then resolved by capillary electrophoresis. Sanger sequencing are primarily used to sequence individual pieces of DNA (such as DNA copied in PCR or bacterial plasmids). It gives high-quality sequence for relatively long stretches of DNA (up to 900 base pairs).

Market Analysis and Insights: Global Sangers Sequencing Service Market
The global Sangers Sequencing Service market size is projected to reach US$ 399.5 million by 2027, from US$ 259.5 million in 2020, at a CAGR of 5.9% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sangers Sequencing Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sangers Sequencing Service market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sangers Sequencing Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sangers Sequencing Service market.

Global Sangers Sequencing Service Scope and Market Size
Sangers Sequencing Service market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sangers Sequencing Service market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Shotgun Sequencing
Targeted Gene Sequencing
Others

Segment by Application
Academic and Government Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Hospitals and Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Source BioScience
GenScript Biotech
Thermo Fisher Scientific
LGC Science Group
Fasteris
CeMIA
Quintara Biosciences
GenHunter
GENEWIZ
Nucleics
SciGenom Labs
Microsynth
Laragen
StarSEQ